Valeant Pharmaceuticals adds prominent U.S. investor John Paulson to board

Valeant Pharmaceuticals adds prominent U.S. investor John Paulson to board


His New York-based investment firm Paulson & Co. is currently Valeant's largest shareholder, with about 5.7 per cent of the Quebec-based company's outstanding shares.



from Biotech News